Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 452.70K | 463.50K | 429.90K | 392.20K | 405.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 452.70K | 463.50K | 429.90K | 392.20K | 405.80K |
| Cost of Revenue | 157.60K | 162.30K | 149.40K | 144.80K | 151.30K |
| Gross Profit | 295.10K | 301.20K | 280.40K | 247.30K | 254.40K |
| SG&A Expenses | 1.47M | 1.31M | 1.21M | 1.13M | 1.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.63M | 1.47M | 1.36M | 1.27M | 1.25M |
| Operating Income | -1.18M | -1.00M | -933.00K | -878.50K | -839.80K |
| Income Before Tax | -1.79M | -1.53M | -2.26M | -1.29M | -1.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.79 | -1.53 | -2.26 | -1.29 | -1.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.79M | -1.53M | -2.26M | -1.29M | -1.30M |
| EBIT | -1.18M | -1.00M | -933.00K | -878.50K | -839.80K |
| EBITDA | -1.17M | -995.00K | -925.20K | -870.90K | -832.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 30.97B | 30.81B | 30.73B | 30.69B | 30.58B |
| Average Diluted Shares Outstanding | 60.96B | 60.80B | 30.73B | 30.69B | 30.58B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |